Differential regulation of interleukin-10 production by genetic and environmental factors

Differential regulation of interleukin-10 production by genetic and environmental factors – a twin study

Published:2002-11 Issue:7 Volume:3 Page:407-413
ISSN:1466-4879
Container-title:Genes & Immunity
language:en
Short-container-title:Genes Immun

Author:

Reuss E,Fimmers R,Kruger A,Becker C,Rittner C,Höhler T

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Immunology

Link

http://www.nature.com/articles/6363920.pdf

Reference36 articles.

1. Mosmann TR . Properties and functions of interleukin-10 Adv Immunol 1994 56: 1–26

2. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A . IL-10 inhibits cytokine production by activated macrophages J Immunol 1991 147: 3815–3822

3. Wanidworanun C, Strober W . Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis J Immunol 1993 151: 6853–6861

4. Rousset F, Garcia E, Defrance T et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes Proc Natl Acad Sci USA 1992 89: 1890–1893

5. Llorente L, Zou W, Levy Y et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus J Exp Med 1995 181: 839–844

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variants of IL-10 promoter influence susceptibility to HIV-1 infection and disease progression in the Polish population;Human Immunology;2024-09

2. Impacts of circulating cytokine levels and gene polymorphism predisposition on type 1 diabetes mellitus;Annals of Pediatric Endocrinology & Metabolism;2024-08-31

3. Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer;Life;2024-08-20

4. Major Adverse Cardiovascular Events: The Importance of Serum Levels and Haplotypes of the Anti-Inflammatory Cytokine Interleukin 10;Biomolecules;2024-08-09

5. Interleukin-10 GCC/GCC haplotype is associated high risk of acute GVHD in patients undergoing allogeneic HSCT in the southern of Brazil;Transplant Immunology;2024-04